Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build Kenya flag

Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions

: Kenya Treatment Intent Code System

Active as of 2026-06-04

Raw json | Download

{
  "resourceType" : "CodeSystem",
  "id" : "treatment-intent-cs",
  "language" : "en",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem treatment-intent-cs</b></p><a name=\"treatment-intent-cs\"> </a><a name=\"hctreatment-intent-cs\"> </a><p>This case-sensitive code system <code>https://nshr-uat.sha.go.ke/fhir/CodeSystem/treatment-intent-cs</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">CURATIVE<a name=\"treatment-intent-cs-CURATIVE\"> </a></td><td>Curative</td><td>Treatment aimed at cure or long-term remission.</td></tr><tr><td style=\"white-space:nowrap\">PALLIATIVE<a name=\"treatment-intent-cs-PALLIATIVE\"> </a></td><td>Palliative</td><td>Treatment aimed at controlling symptoms and improving quality of life.</td></tr><tr><td style=\"white-space:nowrap\">ADJUVANT<a name=\"treatment-intent-cs-ADJUVANT\"> </a></td><td>Adjuvant</td><td>Treatment given after primary therapy to reduce recurrence risk.</td></tr><tr><td style=\"white-space:nowrap\">NEO-ADJUVANT<a name=\"treatment-intent-cs-NEO-ADJUVANT\"> </a></td><td>Neo-adjuvant</td><td>Treatment given before primary therapy to reduce tumour bulk.</td></tr><tr><td style=\"white-space:nowrap\">PROPHYLACTIC<a name=\"treatment-intent-cs-PROPHYLACTIC\"> </a></td><td>Prophylactic</td><td>Treatment to prevent cancer or its recurrence.</td></tr><tr><td style=\"white-space:nowrap\">RADIOSENSITISER<a name=\"treatment-intent-cs-RADIOSENSITISER\"> </a></td><td>Radiosensitiser</td><td>Chemotherapy given concurrently to enhance radiotherapy effect.</td></tr><tr><td style=\"white-space:nowrap\">NOT-APPLICABLE<a name=\"treatment-intent-cs-NOT-APPLICABLE\"> </a></td><td>Not Applicable</td><td>Treatment intent is not applicable or not recorded.</td></tr></table></div>"
  },
  "url" : "https://nshr-uat.sha.go.ke/fhir/CodeSystem/treatment-intent-cs",
  "version" : "0.1.0",
  "name" : "TreatmentIntentCS",
  "title" : "Kenya Treatment Intent Code System",
  "status" : "active",
  "experimental" : false,
  "date" : "2026-06-04T14:49:30+00:00",
  "publisher" : "Digital Health Agency (DHA), Kenya",
  "contact" : [
    {
      "name" : "Digital Health Agency (DHA), Kenya",
      "telecom" : [
        {
          "system" : "url",
          "value" : "https://dha.go.ke"
        },
        {
          "system" : "email",
          "value" : "info@dha.go.ke"
        }
      ]
    },
    {
      "name" : "Digital Health Agency Kenya – FHIR Team",
      "telecom" : [
        {
          "system" : "email",
          "value" : "info@dha.go.ke",
          "use" : "work"
        },
        {
          "system" : "url",
          "value" : "https://dha.go.ke",
          "use" : "work"
        }
      ]
    }
  ],
  "description" : "Codes representing the clinical intent of an oncology treatment.",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "KE",
          "display" : "Kenya"
        }
      ]
    }
  ],
  "caseSensitive" : true,
  "content" : "complete",
  "count" : 7,
  "concept" : [
    {
      "code" : "CURATIVE",
      "display" : "Curative",
      "definition" : "Treatment aimed at cure or long-term remission."
    },
    {
      "code" : "PALLIATIVE",
      "display" : "Palliative",
      "definition" : "Treatment aimed at controlling symptoms and improving quality of life."
    },
    {
      "code" : "ADJUVANT",
      "display" : "Adjuvant",
      "definition" : "Treatment given after primary therapy to reduce recurrence risk."
    },
    {
      "code" : "NEO-ADJUVANT",
      "display" : "Neo-adjuvant",
      "definition" : "Treatment given before primary therapy to reduce tumour bulk."
    },
    {
      "code" : "PROPHYLACTIC",
      "display" : "Prophylactic",
      "definition" : "Treatment to prevent cancer or its recurrence."
    },
    {
      "code" : "RADIOSENSITISER",
      "display" : "Radiosensitiser",
      "definition" : "Chemotherapy given concurrently to enhance radiotherapy effect."
    },
    {
      "code" : "NOT-APPLICABLE",
      "display" : "Not Applicable",
      "definition" : "Treatment intent is not applicable or not recorded."
    }
  ]
}